EVEREST ORGANICS LTD.
Latest filings
- Routine dematerialization compliance certificate for Sep 2026 quarter · Compliance
- 33rd AGM voting results - all 6 resolutions passed · Board & Shareholder Meetings
- 33rd AGM held on Sept 30, 2026 - voting results pending · Board & Shareholder Meetings
Snapshot
What the business is, and whether it's a good one at a fair price.
Manufactures active pharmaceutical ingredients (APIs) and intermediates at a facility in Telangana, with its registered office in Hyderabad. FY26 total income was Rs. 19,615.11 lakhs, an increase of approximately 23% from Rs. 15,941.90 lakhs in FY25 as noted in filings. The business returned to a profit after tax of Rs. 804.68 lakhs after a loss the prior year. Raw materials are the largest cost, accounting for 63.9% of revenue in FY26, followed by other operating expenses at 19.1% and employee costs at 7.9%. The statutory auditor issued a qualified opinion because the company has been operating at enhanced production capacity without the required environmental consents from the Telangana State Pollution Control Board, which the auditor said could affect the going concern status. Management has applied for Consent for Establishment and obtained an Environmental Clearance Certificate.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from EVEREST ORGANICS LTD.'s filed financials and exchange disclosures
What does EVEREST ORGANICS LTD. do?
EVEREST ORGANICS LTD. is a Pharmaceuticals & Biotechnology company listed on BSE.
Is EVEREST ORGANICS LTD. profitable?
Yes. Over the trailing twelve months EVEREST ORGANICS LTD. reported a net profit of ₹5.55 Cr on revenue of ₹196 Cr.
Does EVEREST ORGANICS LTD. pay a dividend?
Not in the latest reported year — EVEREST ORGANICS LTD.'s dividend payout for FY26 was nil.
Is EVEREST ORGANICS LTD. debt-free?
No. It reported borrowings of ₹50 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹50 Cr after cash. Debt stands at 0.66× equity. That is higher than 88% of its 166 Pharmaceuticals peers.
Is EVEREST ORGANICS LTD. expensive compared with its peers?
On trailing P/E, EVEREST ORGANICS LTD. ranks 105 of 158 in Pharmaceuticals — cheaper than 34% of them, against an industry median of 30.8×. This is a position, not a valuation judgement.
How much does the EVEREST ORGANICS LTD. share price move in a day?
On a typical session EVEREST ORGANICS LTD. moves 2.42% — that is the median absolute close-to-close move across its last 266 trading days. MarketPing measures each filing's price reaction against it.
Where can I track EVEREST ORGANICS LTD.'s announcements?
Every NSE and BSE filing by EVEREST ORGANICS LTD. appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.